Test ID: FFTRO
Trofile DNA Co-Receptor Tropism Assay
Method Description
Describes how the test is performed and provides a method-specific reference
Co-receptor tropism is defined as an interaction of a virus with a specific co-receptor on the target cell. To gain entry into CD4+ cells, HIV must bind to the cell surface CD4 receptor and to one of two co-receptors, CCR5 or CXCR4. Trofile DNA uses the complete gp160 coding region of the HIV-1 envelope protein ensuring that all of the determinants of tropism tested.
Trofile DNA meets the US standards for technical validation as established by the Clinical Laboratory Improvement Amendments. Trofile DNA is a single cycle pseudovirion based tropism assay that uses the complete gp160 coding region of HIV-1 to evaluate tropism. Instead of using HIV-1 RNA isolated from patient plasma, Trofile DNA uses cell associated viral DNA taken from whole blood cells infected with HIV. HIV-1 envelopes encoded by the viral DNA are tested in a cell-based viral infectivity assay in order to determine which co- receptor the HIV-1 virus population is capable of using: CCR5, CXCR4, or both, known as D/M (dual/mixed).
Day(s) and Time(s) Test Performed
Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Monday through Friday


